Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

MAP3K13 anticorps (AA 506-835)

MAP3K13 Reactivité: Humain WB, ELISA, IHC Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN7160025
  • Antigène Voir toutes MAP3K13 Anticorps
    MAP3K13 (Mitogen-Activated Protein Kinase Kinase Kinase 13 (MAP3K13))
    Épitope
    • 15
    • 13
    • 7
    • 5
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 506-835
    Reactivité
    • 53
    • 29
    • 14
    • 1
    • 1
    • 1
    • 1
    Humain
    Hôte
    • 50
    • 3
    Lapin
    Clonalité
    • 52
    • 1
    Polyclonal
    Conjugué
    • 18
    • 5
    • 5
    • 4
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp MAP3K13 est non-conjugé
    Application
    • 42
    • 25
    • 16
    • 13
    • 13
    • 6
    • 3
    • 3
    • 2
    • 2
    Western Blotting (WB), ELISA, Immunohistochemistry (IHC)
     Réactivité croisée
    Humain, Souris, Rat
    Purification
    >95%, Protein G purified
    Immunogène
    Recombinant Human Mitogen-activated protein kinase kinase kinase 13 protein (506-835AA)
    Isotype
    IgG
    Top Product
    Discover our top product MAP3K13 Anticorps primaire
  • Indications d'application
    Recommended dilution: WB:1:500-1:5000, IHC:1:20-1:200,
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    Preservative: 0.03 % Proclin 300
    Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4
    Agent conservateur
    ProClin
    Précaution d'utilisation
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    -20 °C,-80 °C
    Stockage commentaire
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Antigène
    MAP3K13 (Mitogen-Activated Protein Kinase Kinase Kinase 13 (MAP3K13))
    Autre désignation
    MAP3K13 (MAP3K13 Produits)
    Synonymes
    anticorps LZK, anticorps MEKK13, anticorps MLK, anticorps C130026N12Rik, anticorps lzk, anticorps map3k13, anticorps map3k13a, anticorps mekk13, anticorps map3k13-a, anticorps map3k13-b, anticorps map3k13b, anticorps mitogen-activated protein kinase kinase kinase 13, anticorps mitogen-activated protein kinase kinase kinase 13 L homeolog, anticorps mitogen-activated protein kinase kinase kinase 13 S homeolog, anticorps MAP3K13, anticorps Map3k13, anticorps map3k13.L, anticorps map3k13, anticorps map3k13.S
    Sujet

    Background: Activates the JUN N-terminal pathway through activation of the MAP kinase kinase MAP2K7. Acts synergistically with PRDX3 to regulate the activation of NF-kappa-B in the cytosol. This activation is kinase-dependent and involves activating the IKK complex, the IKBKB-containing complex that phosphorylates inhibitors of NF-kappa-B.

    Aliases: EC 2.7.11.25 antibody, Leucine zipper bearing kinase antibody, Leucine zipper-bearing kinase antibody, LZK antibody, M3K13_HUMAN antibody, MAP3K13 antibody, MEKK13 antibody, MGC133196 antibody, Mitogen activated protein kinase kinase kinase 13 antibody, Mitogen-activated protein kinase kinase kinase 13 antibody, Mixed lineage kinase antibody, MLK antibody, OTTHUMP00000210397 antibody

    UniProt
    O43283
    Pathways
    Signaling Events mediated by VEGFR1 and VEGFR2
Support technique